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Abstract. A frequent administration of gentamicin in clinical practice has shown its bactericidal activity, and besides 
being vestibulotoxic it is highly nephrotoxic, which can further result in acute renal insufficiency. The study analyzed 
24 Wistar rats, divided into three equal groups. GM group received gentamicin (100 mg/kg), GME group received 
vitamin E (100 mg/kg) and the same dose of gentamicin as GM rats, while the third group served as the control group 
and received saline (1 ml/24h) for 8 days. Pathohistological examination of the kidney tissues from GM group rats 
showed areas of coagulation-type necrosis in a large number of proximal tubules, while their glomeruli were 
considerably enlarged compared both to control and GME group rats. In GME rats, changes in glomeruli were less 
visible, while areas of coagulation-type necrosis were not found.  Biochemical analysis showed significantly higher 
values of blood urea and creatinine in GM group rats in comparison to C group and GME group (p<0.001). The 
concentrations of potassium in blood serum was significantly lower in GM group compared to control group 
(p<0.01), whereas the concentration of sodium was lower, however, without statistical significance. The 
concentrations of AOPP for GM group were significantly higher when compared to C group (p<0.001), whereas the 
values for GME group of rats were statistically significantly lower than AOPP recorded for GM group (p<0.001). 
Our experimental study has shown that gentamicin-induced nephrotoxicity can be significantly reduced by 
simultaneous administration of vitamin E. 




A very frequent administration of the aminoglycoside 
antibiotic gentamicin in the clinical practice has shown 
its undoubted nephrotoxic effect [1]. Even in low 
concentrations, gentamicin shows its bactericidal activity, 
and besides being vestibulotoxic it is highly nephrotoxic, 
which can further result in acute renal insufficiency 
(ARI). Numerous experimental models have confirmed 
the nephrotoxicity induced by gentamicin [2–5], 
cyclosporine [6, 7], cisplatine [8], adriamicin [9], as well as 
other toxic chemical substances such as glycerol [10, 11], 
mercury chloride [12] and others. Nephrotoxicity induced 
in these experimental models showed pathohistological, 
ultrastructural and functional renal impairments in the 
form of tubular desquamation and necrosis and elevated 
blood urea and serum creatinine. The predilection sites 
of damage are the renal cortex, i.e. glomeruli and proximal 
tubules. In the recent years, there have been many studies 
pointing to the significant role of reactive oxygen species 
(ROS) in gentamicin-induced nephrotoxicity [13]. In their 
research, Sha and Schacht [14] showed that aminoglycoside 
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antibiotics can stimulate free radical formation. Therefore, 
it can be claimed with great certainty that gentamicin 
induces ooxidative stress. Kidney cells can produce free 
radicals in glomerular mesangial and endothelial cells 
and in tubular epithelial cells [15]. Epithelial cells of 
proximal tubules are very sensitive to the effects of 
oxygen free radicals as 50% of cells die after being 
exposed to the effect of H2O2 [16]. These free radicals 
destroy the glomerular basement membrane, impair the 
tubular function, degrade the collagen and other 
components of matrix [17]. Because of potential 
gentamicin nephrotoxicity, in the recent years there has 
been much research on the administration of protective 
substances which would prevent or reduce renal 
alterations, and also prevent the onset and development 
of renal insuffuciency. Vitamin E and N-acetyl cysteine 
(NAC) are well known for their antioxidant activities. 
Vitamin E protects unsaturated fatty acids from oxydation 
via peroxide and other free radicals. Vitamin E and NAC 
have shown their protective effects in gentamicin-induced 
nephrotoxicity [18]. Some studies have demonstrated that 
vitamin E and vitamin C reduce the lipid peroxidation and 
increase the activities of antioxidant enzymes in diabetic rat 
kidneys [19]. Vitamin E pretreatment suppresses oxidative 
stess and glomerulosclerosis in experimental rats [20]. The 
administration of single doses of vitamin E has possitive 
effects on cisplatin-induced nephrotoxicity in rat 
development [21].  
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The aim of the research was to show the protective 
effects of vitamin E on gentamicin-induced acute renal 
failure in rats. 
Material and Methods 
Twenty-four adult Wistar rats, weighing 250–300 g, were 
used in the present study. The animals were housed at the 
Institute for Biomedical Research, Faculty of Medicine in 
Niš. The animals were kept in polycarbonate cages under 
controlled conditions with the twelve-hour day/night 
cycle, at the temperature of 20 º C ± 2 º C, and the “ad 
libitum” access to food (“VETFARM”-Beograd) and 
drinking water. All experimental procedures were 
approved by Ethical Committee of Medical Faculty in 
Niš. It was documented under number 01-2625-7. 
Experimental protocol 
Experimental animals were randomly divided into three 
equal groups of 8 animals each, one of which was used 
as a control group. The experimental group of animals 
or GM group was treated with gentamicin (Galenika 
AD, Belgrade, Serbia) intraperitoneally in a dose of 100 
mg /kg body weight (BW)/24h. The experimental group 
of animals treated with gentamicin and vitamin E or 
GME group received oily solution of vitamin E 
(Pharmamagist, Hungary) intraperitoneally in a dose of 
100 mg/kg BW/24h and the application of the same 
dose of gentamicin as in the first group of rats. The 
control group of animals received physiological saline 
solution 1 ml/day intraperitoneally. All groups were treated 
over a period of 8 consecutive days. Following the last 
application, that is 9 days after the beginning of the 
experiment, all animals were anaesthetized using ketamine 
at a dose of 80 mg/kg (10% Ketamidor, Richter pharma 
AG, Wien, Austria). Blood samples were taken from the 
aorta (2ml), and the kidneys were subsequently removed. 
Histological analysis 
The kidneys were dissected out, washed and fixed in 
10% paraformaldehyde (in 0.1M phosphate buffer 
saline), dehydrated in ascending graded series of alcohol 
and processed for paraffin embedding. Kidney tissue 
species were cut at a thickness of 5µm using a HistoRange 
microtome (model: LKB 2218, LKB-Produkter AB, 
Bromma, Sweden) and stained with hematoxylin–eosin 
(HE) for the study of morphological changes in the 
kidney and PAS (Periodic Acid Schiff) for verifying the 
content of glycogen, according to conventional staining 
protocols. For histopathological examination of kidney 
tissue the microscope (LEICA DM 2000 LED) and 
digital camera (LEICA DFC 450) were used.  
Biochemical analysis 
Blood samples were analyzed for markers of kidney 
function impairment. Urea, creatinine, sodium and 
potassium concentrations in serum were measured in the 
laboratory of the Department of Nephrology and Dialysis 
Clinical Center Niš using an automatic biochemical 
analyzer (A25 Biosystems, Barcelona, Spain). 
Determination of protein oxidation 
To determine the concentration of advanced oxidation 
protein products (AOPP) as a marker of oxidative 
modified proteins, kidney tissue was minced and 
homogenized in ice-water with homogenizer (IKA 
Works de Brasil Ltda Taquara, RJ 22, 713-00). Proteins 
were measured according to Lowry’s method [22] using 
bovine serum as standard. The concentration of AOPP 
in the renal homogenates was determined by 
spectrophotometric method by Witko-Sarsat [23]. This 
method is based on the reaction of AOPP with potassium 
iodide in an acidic medium. The color intensity was 
recorded immediately at 340 nm. The concentrations 
were expressed in µmol/mg protein.  
Statistical analysis 
Statistical analysis of the data obtained by biochemical 
blood analysis were expressed as mean values and standard 
deviations, and statistical significance was determined by 
one-way analysis of variance (ANOVA) followed by 
Tukey’s post hoc test for multiple comparison (Graphpad 
Prism 5.03, San Diego, CA, USA). 
Results 
Histological analysis 
In the GM group of rats, a large number of proximal 
tubules, especially initial convoluting portions, showed 
coagulation-type necrosis and apoptosis with cytoplasm 
vacuolation, desquamation and inflammatory cell 
infiltration in cells still containing nuclei. Glomeruli in 
this group were enlarged and paler (Fig. 1) than in the 
control group of animals (Figs. 2 and 3). In experimental 
group treated with gentamicin some of glomerular 
capillaries were infiltrated with neutrophil leukocytes 
 
Fig. 1. Histopathological tissue features of renal glomeruli 
and tubules of gentamicin-treated (GM) group of 
rats. HE,  200. 
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(Fig. 4). The distal tubules were of normal appearance. 
In the GME group, glomeruli were somewhat enlarged 
and hyaline cylinders in some proximal tubules were 
present; the areas of coagulation-type necrosis were not 
found (Figs. 5 and 6). 
 
Fig. 2. Histopathological tissue features of renal glomeruli 
and tubules of control group of rats. HE,  200. 
 
Fig. 3. Histopathological tissue features of renal glomeruli 
and tubules  of control group of rats. PAS,  400. 
 
Fig. 4. Histopathological tissue features of renal glomeruli 
and tubules of gentamicin-treated (GM) group of 
rats. PAS,  400. 
 
Fig. 5. Histopathological tissue features of renal glomeruli 
and tubules of gentamicin plus vitamin E-treated 
(GME) group of rats. HE,  200. 
 
Fig. 6. Histopathological tissue features of renal glomeruli 
and tubules of gentamicin plus vitamin E-treated 
(GME) group of rats. PAS,  400. 
Biochemical analysis 
Analysis of biochemical parameters showed a significant 
increase of urea and creatinine serum concentrations in 
the GM group compared to the C group (p<0.001). The 
concentration of potassium in the blood was significantly 
decreased in the GM group than concentration in the 
control group (p<0.01), while the concentration of 
sodium was lower, but not with statistical significance in 
comparison to the C group. In the GME group, creatinine 
and urea concentrations were significantly elevated 
compared to the control group (p<0.01), but also these 
values were significantly decreased compared to the GM 
group (p<0.001). The concentrations of potassium and 
sodium in the GME-group were not significantly 
different compared to the other groups (Table 1). 
Determination of protein oxidation 
Analysis of oxidative stress marker AOPP showed 
significantly elevated renal AOPP in the GM group than 
in control group of rats (p<0.001). Simultaneous 
administration of vitamin E with gentamicin reduced 
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oxidative stress, as evidenced by significantly decreased 
level of renal AOPP than those in the GM group 
(p<0.001). 
Table 1. Biochemical analysis of serum levels of 
creatinine, urea and electrolytes in the control 
and experimental groups of rats 
Serum 
concentration 
C-group GM-group GME-group 
Creatinine 
(µmol/L) 
57.03 ±10.89 380.5 ± 29.47#  91.4 ± 9.987* ## 
Urea       
(mmol/L) 
 6.57 ± 0.577 30.27 ± 6.096#  12.73 ± 1.875* ## 
Potassium 
(mmol/L) 
 5.513± 0.5668  4.588 ± 0.4486##  4.988 ± 0.4549 
Sodium  
(mmol/L) 
143.1 ± 2.031 141.6 ± 2.2 143.6 ± 1.302 
#
 p<0.001 vs. C-group, 
##
 p<0.01 vs. C-group, 
*














# p<0.001 vs. C-group







Fig. 7. Renal AOPP values in the control and experimental 
groups of rats.  
 # p<0.001 vs. C-group, * p<0.001 vs. GM-group 
Discussion  
Due to its strong bactericidal activity, gentamicin is a 
widely used antibiotic in the management of infections 
caused by gram-negative microorganisms. However, 
literature data point to its nephrotoxic effect which has 
been demonstrated in a large number of experimental 
studies in which gentamicin acute renal insifficiency 
was induced [24, 25].  
Proximal tubule cells are severely damaged in patients 
treated with gentamicin or amicacin [26]. Gentamicin 
binds the cell wall phospholipids, blocking thus the chain 
reaction of phosphatidylinositol, which impairs the cell 
integrity [27]. The mechanism of gentamicin nephrotoxicity 
is complex and has not been elucidated yet. Having been 
administered, gentamicin reaches the renal cortex, binds 
the proximal tubule apical membrane, and then, by means 
of pinocytosis, reaches the epithelial cells of proximal 
tubules where it interacts with cell organelles, specifically 
with lysosomes and mitochondria. This further causes 
lysosomal destabilization, release of lysosomal enzymes 
and cell damage.  
Pathohistological changes, confirmed by light 
microscopy, in our experimental group of rats treated 
with gentamicin (GM group) included the enlargement 
of glomeruli as well as the presence of neutrophil 
leukocytes in certain glomerular capillaries. The changes 
in the proximal tubules were dominant and manifested 
in the form of coagulation-type necrosis, cytoplasm 
vacuolization of tubular epithelial cells with preserved 
nuclei. The structural changes in the distal tubules were 
not found. These changes are mostly in keeping with the 
changes already described by other authors [28, 29]. In 
the mentioned group of animals (GM group), the 
biochemical analyses showed the most significant 
elevation of urea and creatinine levels in the serum as a 
sign of alterations of kidney, whereas the values of 
sodium did not statistically differ in all three groups of 
animals. The values of serum potassium in GM group 
were statistically significantly reduced in relation to the 
group of animals treated with gentamicin and vitamin E, 
as well as the control group. This is quite common 
having in mind that morphological change in the 
proximal tubules reduce potassium reabsorption, and 
consequently increases the urinary excretion of this 
electrolyte. Matsuda et al. [30] showed that the electrolyte 
composition of the renal tubular cells in gentamicin 
nephrotoxicity was different in relation to the necrotic 
and non-necrotic tubular cells of the proximal tubules. 
They demonstrated that histological impairment was 
present only in the proximal tubules, and that the 
concentrations of sodium and potassium in the necrotic 
tubular cells were somewhat lower than in the controls, 
whereas the concentrations of sodium in the non-
necrotic cells of proximal tubules were slightly higher in 
relation to the control group of animals. This indicates 
that potassium serum levels correlate with the 
histopathological findings in the proximal tubule cells 
where gentamicin expresses its main nephrotoxic effect, 
which is in keeping with our results. The presence of 
neutrophils in the glomerular capillaries indicates that 
the administration of gentamicin impaired the renal 
microcirculation and glomerular hemodynamics. If the 
changes in the kidneys and glomeruli are primarily due 
to changed microcirculation and hemodynamics in the 
capillaries, the removal of these would annul gentamicin 
effects in renal nephrotoxicity. On the other hand, 
gentamicin induces oxidative stress, and achieves direct 
effects by means of ROS which show particular affinity 
for the endothelial cells of blood vessels. This induces 
the loss of the architectonics of the endothelial cells’ 
cytoskeleton and organelles, impairs the cell membrane 
transport mechanism as well as the activity of intracellular 
enzyme systems. It has been proved that aminoglycoside 
antibiotics have harmful effects to the kidneys as they 
produce ROS [14]. At increased concentrations the 
antioxidant vitamins inhibit pathological states.  
Vitamin E is the main endogenous antioxidant which 
reacting with oxygen radical prevents the chain reaction 
of free radicals, protecting thus the membrane. However, 
the endogenous antioxidants reserves, such as vitamin 
E, gradually decrease in reactions with free radicals 
[31]. In our experimental group of animals treated with 
gentamicin and vitamin E, histological and histochemical 
analyses of glomeruli and proximal tubules demonstrated 
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slightly increased glomeruli, whereas the changes on the 
proximal tubule epithelial cells were expressed in the 
form of vacuolization without any signs of necrosis. In 
GME group, the values of creatinine and urea were 
statistically significantly different in relation to the 
control group (p<0.01) and GM group (p<0.001) as well. 
The sodium and potassium serum concentrations in GM 
group were not statistically significantly different 
compared to the control group of animals. Similar to our 
results, the combination of vitamin E and probucol has 
proved to be efficient for the improvement of the renal 
function parameters and level of antioxidant enzymes in 
gentamicin-induced toxicity [32]. In other studies, a 
synergy between vitamin E and selenium in diminishing 
renal impairment has been found [3, 25]. Some studies 
have shown that vitamins C and E in combination 
provide more efficient antioxidant properties and better 
effects in gentamicin-induced nephrotoxicity [31]. The 
results of our study are in keeping with hypotheses that 
oxidative stress is one of the causes of gentamicin-
induced renal impairment. The levels of AOPPs in the 
kidney homogenate of gentamicin-treated rats were 
significantly higher when compared with the levels of 
this marker in control group of animals. Witko-Sarsat et 
al. [23] have shown that in vivo AOPPs levels correlate 
with creatinine clearance, indicating that AOPPs are an 
excellent biomarker of chronic renal impairment. That 
AOPPs are useful biomarkers in acute renal insufficiency 
has been pointed out by Kimoto et al. [33] when they 
determined this parameter in cisplatin-induced 
nephrotoxicity. It is well known that vitamin E acts as an 
antioxidant within cells, and the mechanisms which 
contribute to its efficacy involve the suppression of free 
radicals and improvement in antioxidant system status 
[34]. In this paper, we confirmed the antioxidant properties 
of vitamin E, which was supported by statistically 
significantly lower AOPPs levels in rats simultaneously 
treated with vitamin E and gentamicin in relation to the 
group of rats treated with gentamicin alone. 
Conclusion  
Our experimental study showed that gentamicin-induced 
nephrotoxicity can be significantly reduced by 
simultaneous administration of vitamin E as a very 
significant antioxidant. 
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